-+ 0.00%
-+ 0.00%
-+ 0.00%

CATALYST PHARMACEUTICALS - VAMOROLONE SHOWS NO SIGNIFICANT IMMUNOSUPPRESSION AT CLINICAL DOSES IN PHASE 1 STUDY

Reuters·06/30/2026 12:03:00

Please log in to view news